HUMAN CYTOMEGALOVIRUS VACCINE

The disclosure relates to HCMV ribonucleic acid (RNA) vaccines, as well as methods of using the vaccines and compositions comprising the vaccines.

Saved in:
Bibliographic Details
Main Authors Ciaramella, Giuseppe, John, Shinu
Format Patent
LanguageEnglish
Published 09.02.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The disclosure relates to HCMV ribonucleic acid (RNA) vaccines, as well as methods of using the vaccines and compositions comprising the vaccines.
Bibliography:Application Number: US202217839401